{
    "code": "02023780",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02023780",
    "time": "2020-05-08 04:14:23",
    "許可證字號": "衛署藥輸字第023780號",
    "註銷狀態": "已註銷",
    "註銷日期": "109\/04\/07",
    "註銷理由": "屆期未申請展延",
    "製造許可登錄編號": "",
    "有效日期": "107\/07\/21",
    "發證日期": "92\/07\/21",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202378007",
    "中文品名": "普利脈注射劑",
    "英文品名": "BLENAMAX 15U, POWDER FOR INJECTION",
    "適應症": "頭、頸部癌(上顎癌、舌、口唇、咽喉、口腔等癌)、皮膚癌(包括陰莖、陰囊及婦女外陰癌等)、肺癌(原發性及轉移性扁平上皮癌)、食道癌、惡性淋巴腫(細菌肉腫、淋巴肉腫、何杰金氏病)。",
    "劑型": "243凍晶注射劑",
    "包裝": "10公撮小瓶",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "Bleomycin (sulfate)",
    "限制項目": "02輸　入",
    "申請商名稱": "620102K944  香港商艾維斯有限公司台灣分公司",
    "申請商地址": "台北市中正區忠孝東路二段116號10樓",
    "主製造廠": [
        {
            "製造廠名稱": "FNL0029100  PHARMACHEMIE B.V.",
            "製造廠廠址": "SWENSWEG 5,2031 GA HAARLEM,THE NETHERLANDS",
            "製造廠公司地址": "P.O. BOX 552,2003 RN HAARLEM,THE NETHERLANDS",
            "製造廠國別": "NETHERLANDS",
            "製程": ""
        }
    ],
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1003000230",
            "成分名稱": "Bleomycin (sulfate)",
            "含量描述": "",
            "含量": "15.0000000000",
            "單位": "I.U."
        }
    ]
}